MeasurableQuantitativeAnnotation  

PubMed:32031570 JSONTXT 38 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
E1 1222-1232 entity denotes median age
N1 1237-1239 num denotes 56
U1 1240-1245 unit denotes years
N1 1299-1301 num denotes 75
N2 1303-1307 num denotes 54.3
U1 1307-1308 unit denotes %
E1 1315-1318 entity denotes men
E1 1516-1521 entity denotes fever
N1 1523-1526 num denotes 136
N2 1528-1532 num denotes 98.6
U1 1532-1533 unit denotes %
E2 1537-1544 entity denotes fatigue
N3 1546-1548 num denotes 96
N4 1550-1554 num denotes 69.6
U2 1554-1555 unit denotes %
E3 1563-1572 entity denotes dry cough
N5 1574-1576 num denotes 82
N6 1578-1582 num denotes 59.4
U3 1582-1583 unit denotes %
E1 1587-1598 entity denotes Lymphopenia
E4 1600-1616 entity denotes lymphocyte count
N7 1618-1627 num denotes 0.8 × 109
U4 1627-1629 unit denotes /L
N1 1680-1682 num denotes 97
N2 1693-1697 num denotes 70.3
U1 1697-1698 unit denotes %
E2 1701-1727 entity denotes prolonged prothrombin time
N3 1763-1765 num denotes 80
N4 1776-1778 num denotes 58
U2 1778-1779 unit denotes %
E3 1786-1816 entity denotes elevated lactate dehydrogenase
N5 1845-1847 num denotes 55
N6 1858-1862 num denotes 39.9
U3 1862-1863 unit denotes %
E1 2008-2025 entity denotes antiviral therapy
E2 2027-2038 entity denotes oseltamivir
N1 2040-2043 num denotes 124
N2 2045-2049 num denotes 89.9
U1 2049-2050 unit denotes %
E3 2072-2093 entity denotes antibacterial therapy
E4 2095-2107 entity denotes moxifloxacin
N3 2109-2111 num denotes 89
N4 2113-2117 num denotes 64.4
U2 2117-2118 unit denotes %
E1 2121-2132 entity denotes ceftriaxone
N1 2134-2136 num denotes 34
N2 2138-2142 num denotes 24.6
U1 2142-2143 unit denotes %
E1 2146-2158 entity denotes azithromycin
N1 2160-2162 num denotes 25
N2 2164-2168 num denotes 18.1
U1 2168-2169 unit denotes %
E2 2176-2198 entity denotes glucocorticoid therapy
N3 2200-2202 num denotes 62
N4 2204-2208 num denotes 44.9
U2 2208-2209 unit denotes %
E1 2327-2362 entity denotes acute respiratory distress syndrome
N1 2364-2366 num denotes 22
N2 2368-2372 num denotes 61.1
U1 2372-2373 unit denotes %
E2 2377-2387 entity denotes arrhythmia
N3 2389-2391 num denotes 16
N4 2393-2397 num denotes 44.4
U2 2397-2398 unit denotes %
E3 2406-2411 entity denotes shock
N5 2413-2415 num denotes 11
N6 2417-2421 num denotes 30.6
U3 2421-2422 unit denotes %
E1 2655-2665 entity denotes median age
N1 2667-2669 num denotes 66
U1 2670-2675 unit denotes years
N2 2679-2681 num denotes 51
U2 2682-2687 unit denotes years
E4 2715-2739 entity denotes underlying comorbidities
N11 2741-2743 num denotes 26
N12 2745-2749 num denotes 72.2
U7 2749-2750 unit denotes %
N13 2755-2757 num denotes 38
N14 2759-2763 num denotes 37.3
U8 2763-2764 unit denotes %
E2 2797-2804 entity denotes dyspnea
N3 2806-2808 num denotes 23
N4 2810-2814 num denotes 63.9
U3 2814-2815 unit denotes %
N5 2820-2822 num denotes 20
N6 2824-2828 num denotes 19.6
U4 2828-2829 unit denotes %
E3 2837-2845 entity denotes anorexia
N7 2847-2849 num denotes 24
N8 2851-2855 num denotes 66.7
U5 2855-2856 unit denotes %
N9 2861-2863 num denotes 31
N10 2865-2869 num denotes 30.4
U6 2869-2870 unit denotes %
N1 2902-2903 num denotes 4
N2 2905-2909 num denotes 11.1
U1 2909-2910 unit denotes %
E1 2912-2945 entity denotes received high-flow oxygen therapy
N3 2947-2949 num denotes 15
N4 2951-2955 num denotes 41.7
U2 2955-2956 unit denotes %
E2 2958-2990 entity denotes received noninvasive ventilation
N5 2996-2998 num denotes 17
N6 3000-3004 num denotes 47.2
U3 3004-3005 unit denotes %
E3 3007-3036 entity denotes received invasive ventilation
N1 3153-3154 num denotes 6
E1 3155-3159 entity denotes died
E2 3161-3178 entity denotes overall mortality
N2 3180-3183 num denotes 4.3
U1 3183-3184 unit denotes %
R1 E1 N1 associateWith died,6
R1 E1 N1 associateWith died,6
R1 E1 N1 associateWith died,6
R1 E1 N1 associateWith died,6
R1 E1 N1 associateWith died,6
R1 E1 N1 associateWith died,6
R1 E1 N1 associateWith died,6
R1 E1 N1 associateWith died,6
R1 E1 N1 associateWith died,6
R1 E1 N1 associateWith died,6
R1 E1 N1 associateWith died,6
R10 E4 N4 associateWith underlying comorbidities,41.7
R10 N6 U4 associateOf 47.2,%
R11 E3 N7 associateWith received invasive ventilation,24
R12 E3 N8 associateWith received invasive ventilation,66.7
R13 N8 U5 associateOf 66.7,%
R14 E3 N9 associateWith received invasive ventilation,31
R15 E3 N10 associateWith received invasive ventilation,30.4
R16 N10 U6 associateOf 30.4,%
R17 E4 N11 associateWith underlying comorbidities,26
R18 E4 N12 associateWith underlying comorbidities,72.2
R19 E4 N13 associateWith underlying comorbidities,38
R2 N1 U1 associateOf 6,%
R2 E1 N2 associateWith died,4.3
R2 E1 N2 associateWith died,4.3
R2 E1 N2 associateWith died,4.3
R2 E1 N2 associateWith died,4.3
R2 E1 N2 associateWith died,4.3
R2 E1 N2 associateWith died,4.3
R2 E1 N2 associateWith died,4.3
R2 N1 U1 associateOf 6,%
R2 E1 N2 associateWith died,4.3
R2 E2 N2 associateWith overall mortality,4.3
R20 E4 N14 associateWith underlying comorbidities,37.3
R21 N12 U7 associateOf 72.2,%
R22 N14 U8 associateOf 37.3,%
R3 N2 U1 associateOf 4.3,%
R3 N2 U1 associateOf 4.3,%
R3 N2 U1 associateOf 4.3,%
R3 N2 U1 associateOf 4.3,%
R3 N2 U1 associateOf 4.3,%
R3 N2 U1 associateOf 4.3,%
R3 N2 U1 associateOf 4.3,%
R3 E1 N2 associateWith died,4.3
R3 N2 U1 associateOf 4.3,%
R3 N2 U1 associateOf 4.3,%
R4 E2 N3 associateWith overall mortality,15
R4 E2 N3 associateWith overall mortality,15
R4 E2 N1 associateWith overall mortality,6
R4 E2 N3 associateWith overall mortality,15
R4 E2 N3 associateWith overall mortality,15
R4 N2 U2 associateOf 4.3,%
R4 E2 N3 associateWith overall mortality,15
R5 E2 N4 associateWith overall mortality,41.7
R5 E2 N4 associateWith overall mortality,41.7
R5 E2 N2 associateWith overall mortality,4.3
R5 E2 N4 associateWith overall mortality,41.7
R5 E2 N4 associateWith overall mortality,41.7
R5 E2 N3 associateWith overall mortality,15
R5 E2 N4 associateWith overall mortality,41.7
R6 N4 U2 associateOf 41.7,%
R6 N4 U2 associateOf 41.7,%
R6 E3 N3 associateWith received invasive ventilation,15
R6 N4 U2 associateOf 41.7,%
R6 N4 U2 associateOf 41.7,%
R6 E2 N4 associateWith overall mortality,41.7
R6 N4 U2 associateOf 41.7,%
R7 E3 N5 associateWith received invasive ventilation,17
R7 E3 N5 associateWith received invasive ventilation,17
R7 E3 N4 associateWith received invasive ventilation,41.7
R7 E3 N5 associateWith received invasive ventilation,17
R7 N4 U3 associateOf 41.7,%
R7 E3 N5 associateWith received invasive ventilation,17
R8 E3 N6 associateWith received invasive ventilation,47.2
R8 E3 N6 associateWith received invasive ventilation,47.2
R8 N4 U2 associateOf 41.7,%
R8 E3 N6 associateWith received invasive ventilation,47.2
R8 E2 N5 associateWith overall mortality,17
R8 E3 N6 associateWith received invasive ventilation,47.2
R9 N6 U3 associateOf 47.2,%
R9 N6 U3 associateOf 47.2,%
R9 E4 N3 associateWith underlying comorbidities,15
R9 N6 U3 associateOf 47.2,%
R9 E2 N6 associateWith overall mortality,47.2
R9 N6 U3 associateOf 47.2,%